MD Anderson Cancer Center/University of Texas MD Anderson CC Trials

MD Anderson Cancer Center/University of Texas MD Anderson CC	Welcome, Profile Billing Logout

MD Anderson Cancer Center/University of Texas MD Anderson CC

Welcome, Profile Billing Logout

2 Trials

1 Trials

Active Trials Industry lead sponsorIndustry collaborator

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Orlowski, Robert

NCT05698303: A Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A) in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

Not yet recruiting

Fully human BCMA chimeric antigen receptor autologous T cell injection (CT103A), CT103A

Nanjing IASO Biotherapeutics Co.,Ltd

Multiple Myeloma

05/24

01/26

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites